Tiger Brokers

  • Quotes
  • Products
    • Cash Boost Account
    • Singapore Stocks
    • US Stocks
    • US Fractional Shares
    • HK Stocks
    • China A-shares
    • Options
    • Futures
    • US Treasury
    • Auto-invest
    • Fixed Coupon Notes
    • Tiger BOSS Debit Card
    • Fund Mall
    • Tiger Vault
    • Tiger Open Platform
    • Wealth
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Tiger Vault
      • Features of Tiger Vault
      • Transaction Fees
    • Statement
      • Statement
      • Dividends
  • Learn
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
  • Careers
    • L.E.A.P Programme
    • Investment Representative
    • Careers Portal
  • LOGIN
  • SIGN UP
HK StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

ASCLETIS-B

13.680
+1.77014.86%
Volume:21.15M
Turnover:265.72M
Market Cap:13.19B
PE:-41.70
High:13.770
Open:11.630
Low:10.800
Close:11.910
52wk High:13.770
52wk Low:0.760
Shares:964.00M
HK Float Shares:964.00M
Volume Ratio:4.21
T/O Rate:2.19%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.328
ROE:-13.97%
ROA:-10.96%
PB:6.14
PE(LYR):-41.70
PS:9413.49

Loading ...

OverviewCompanyNewsFilings

HK Movers | Biotech Stocks Rally With Zai Lab up 8%

Tiger Newspress
·
Apr 23

HK Movers|HK Pharma Stocks Shined. Ascletis up 18%; Dualitybio up 8%; Zai Lab, HBM and Remegen Up 6%.

Tiger Newspress
·
Apr 22

Ascletis Pharma Reports Positive Interim Results for Obesity Treatment; Shares Up 6%

MT Newswires Live
·
Apr 01

BRIEF-Ascletis Announces Positive Interim Results from Its U.S. Phase Ib Trial with ASC30, a Potentially First-in-Class Subcutaneous Injection Small Molecule GLP-1R Agonist

Reuters
·
Mar 31

Ascletis Pharma's Attributable Loss Widens in 2024 as Revenue Plummets

MT Newswires Live
·
Mar 27

BUZZ-China's Ascletis hits 6-year peak on good results for weight loss drug

Reuters
·
Mar 12

Ascletis' Anti-Obesity Drug Found Safe in Australia Phase 1B Trial; Shares Rise 6%

MT Newswires Live
·
Mar 12

BRIEF-Ascletis Pharma Announces Positive Phase Ib Results And FDA Clearance

Reuters
·
Mar 12

Analyst Rate

Buy
Buy
80.00%
Hold
20.00%
Sell
0.00%

Corporate Actions

Financial Report Announcement
Aug 15, 2025
Financial Report Announcement
Mar 26, 2025 Pre-Market
Financial Report Announcement
Aug 30, 2024
Financial Report Announcement
Mar 25, 2024
Financial Report Announcement
Aug 21, 2023

Dividend History

no data

No relevant data is available

Valuation Analysis

-34.86
Current
-14.77
Sector Average
0.08%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-34.86
Maximum
-3.06
+1 STD
-6.76
Minimum
-34.86
-1 STD
-22.78
Average
-14.77

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Fintech (Singapore) Pte. Ltd.
Email Address:
uservice@ttm.financial
User Agreement|Privacy Policy

Copyright © Tiger Fintech (Singapore) Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.